Table 2. Clinical characteristics of HIV patients co-infected with TB in the Fako Division from 2010 to 2017.
| Variables | Category | Frequency (%) |
|---|---|---|
| TB category | New | 938(90.1) |
| Relapse | 36(3.5) | |
| Treatment failure | 8(0.8) | |
| Retreatment | 14(1.3) | |
| Transferred in | 45(4.3) | |
| Total | 1,041(100.0) | |
| ART regimen at TB diagnosis | Yes | 925(88.9) |
| No | 116(11.1) | |
| Total | 1,041(100.0) | |
| Cotrimoxazole treatment at TB diagnosis | Yes | 989(95.0) |
| No | 52(5.0) | |
| Total | 1,041(100.0) | |
| Phase of treatment at occurrence of TB outcome | No DOT | 24(2.3) |
| Intensive phase of DOT | 179(17.2) | |
| Continuation phase of DOT | 38(3.7) | |
| DOT full course | 800(76.8) | |
| Total | 1,041(100.0) | |
| Number of follow-up diagnosis | One | 143(13.7) |
| Two | 62(6.0) | |
| Three | 37(3.6) | |
| Four | 799(76.8) | |
| Total | 1,041(100.0) |